Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity
- PMID: 11289047
- DOI: 10.2337/diabetes.50.4.817
Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity
Abstract
In obesity and type 2 diabetes, skeletal muscle has been observed to have a reduced oxidative enzyme activity, increased glycolytic activity, and increased lipid content. These metabolic characteristics are related to insulin resistance of skeletal muscle and are factors potentially related to muscle fiber type. The current study was undertaken to examine the interactions of muscle fiber type in relation to oxidative enzyme activity, glycolytic enzyme activity, and muscle lipid content in obese and type 2 diabetic subjects compared with lean healthy volunteers. The method of single-fiber analysis was used on vastus lateralis muscle obtained by percutaneous biopsy from 22 lean, 20 obese, and 20 type 2 diabetic subjects (ages 35+/-1, 42+/-2, and 52+/-2 years, respectively), with values for BMI that were similar in obese and diabetic subjects (23.7+/-0.7, 33.2+/-0.8, and 31.8+/-0.8 kg/m2, respectively). Oxidative enzyme activity followed the order of type I > type IIa > type IIb, but within each fiber type, skeletal muscle from obese and type 2 diabetic subjects had lower oxidative enzyme activity than muscle from lean subjects (P < 0.01). Muscle lipid content followed a similar pattern in relation to fiber type, and within each fiber type, muscle from obese and type 2 diabetic subjects had greater lipid content (P < 0.01). In summary, based on single-fiber analysis, skeletal muscle in obese and type 2 diabetic subjects mani-fests disturbances of oxidative enzyme activity and increased lipid content that are independent of the effect of fiber type.
Similar articles
-
Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus.Acta Diabetol. 2013 Oct;50(5):705-12. doi: 10.1007/s00592-012-0379-0. Epub 2012 Feb 19. Acta Diabetol. 2013. PMID: 22350135
-
Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes.Diabetes Care. 2006 Apr;29(4):895-900. doi: 10.2337/diacare.29.04.06.dc05-1854. Diabetes Care. 2006. PMID: 16567834
-
GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease?Diabetes. 2001 Jun;50(6):1324-9. doi: 10.2337/diabetes.50.6.1324. Diabetes. 2001. PMID: 11375332
-
Metabolic control of myofibers: promising therapeutic target for obesity and type 2 diabetes.Obes Rev. 2017 Jun;18(6):647-659. doi: 10.1111/obr.12530. Epub 2017 Apr 9. Obes Rev. 2017. PMID: 28391659 Review.
-
A primary reduced TCA flux governs substrate oxidation in T2D skeletal muscle.Curr Diabetes Rev. 2012 Nov;8(6):458-79. doi: 10.2174/157339912803529841. Curr Diabetes Rev. 2012. PMID: 22934552 Review.
Cited by
-
Insulin Resistance Is Not Associated with an Impaired Mitochondrial Function in Contracting Gastrocnemius Muscle of Goto-Kakizaki Diabetic Rats In Vivo.PLoS One. 2015 Jun 9;10(6):e0129579. doi: 10.1371/journal.pone.0129579. eCollection 2015. PLoS One. 2015. PMID: 26057538 Free PMC article.
-
Effects of hyperbaric oxygen on metabolic capacity of the skeletal muscle in type 2 diabetic rats with obesity.ScientificWorldJournal. 2012;2012:637978. doi: 10.1100/2012/637978. Epub 2012 Jun 18. ScientificWorldJournal. 2012. PMID: 22778702 Free PMC article.
-
Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease.Wiley Interdiscip Rev Dev Biol. 2016 Jul;5(4):518-34. doi: 10.1002/wdev.230. Epub 2016 May 19. Wiley Interdiscip Rev Dev Biol. 2016. PMID: 27199166 Free PMC article. Review.
-
Intrasample variability of intramyocellular triacylglycerol.Lipids. 2006 Aug;41(8):759-61. doi: 10.1007/s11745-006-5028-3. Lipids. 2006. PMID: 17120929
-
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8466-71. doi: 10.1073/pnas.1032913100. Epub 2003 Jun 27. Proc Natl Acad Sci U S A. 2003. PMID: 12832613 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical